Metabolic reprogramming and therapeutic resistance in primary and metastatic breast cancer
Abstract Metabolic alterations, a hallmark of cancer, enable tumor cells to adapt to their environment by modulating glucose, lipid, and amino acid metabolism, which fuels rapid growth and contributes to treatment resistance. In primary breast cancer, metabolic shifts such as the Warburg effect and...
Saved in:
| Main Authors: | Shan Liu, Xingda Zhang, Wenzheng Wang, Xue Li, Xue Sun, Yuqian Zhao, Qi Wang, Yingpu Li, Fangjie Hu, He Ren |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-11-01
|
| Series: | Molecular Cancer |
| Online Access: | https://doi.org/10.1186/s12943-024-02165-x |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Metabolic reprogramming in cancer: Mechanisms and therapeutics
by: Shiqi Nong, et al.
Published: (2023-04-01) -
Afatinib boosts CAR-T cell antitumor therapeutic efficacy via metabolism and fate reprogramming
by: Xi Zhang, et al.
Published: (2024-11-01) -
Metabolic reprogramming of glucose: the metabolic basis for the occurrence and development of hepatocellular carcinoma
by: Kai Wang, et al.
Published: (2025-02-01) -
Metabolic reprogramming in lung cancer and its clinical implication
by: Qingqiu Huang, et al.
Published: (2024-12-01) -
Bioinformatics-based analysis of fatty acid metabolic reprogramming in hepatocellular carcinoma: cellular heterogeneity, therapeutic targets, and drug discovery
by: Yingying Guo, et al.
Published: (2024-11-01)